Project PRIMAL-MDSC – Role of myeloid derived suppressor cells (MDSC) in intestinalinflammation and microbiome development

Basic data

Acronym:
PRIMAL-MDSC
Title:
Role of myeloid derived suppressor cells (MDSC) in intestinalinflammation and microbiome development
Duration:
01/12/2017 to 30/11/2021
Abstract / short description:
The intestinal microbiome contributes to health maintenance. Pathological alterations in the
microbiome, the so called dysbiosis, may predispose to a variety of diseases. The main microbiome development starts directly after birth, with billions of bacteria encountering the newborns gut. To date it is mainly unknown how the neonatal immune system regulates this colonisation process and balance tolerance of symbiotic flora and protection from pathogens with an adequate inflammatory response. Myeloid derived suppressor cells are immature immune cells with anti-inflammatory activity. MDSC have been found in high numbers in the newborn. In this project the role of MDSC for control of intestinal inflammation during microbiome development will be analyzed. The results will help finding therapies contributing to a healthy development of the microbiome.
Keywords:
microbiome
newborn
dysbiosis

Staff

Managers

Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Local organizational units

Faculty of Medicine
University of Tübingen

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.